Elimination of lymphatic filariasis

Slides:



Advertisements
Similar presentations
Multifaceted roles for lipids in viral infection Nicholas S. Heaton, Glenn Randall Trends in Microbiology Volume 19, Issue 7, Pages (July 2011)
Advertisements

Ancient Endo-siRNA Pathways Reveal New Tricks Julie M. Claycomb Current Biology Volume 24, Issue 15, Pages R703-R715 (August 2014) DOI: /j.cub
Two views of brain function Marcus E. Raichle Trends in Cognitive Sciences Volume 14, Issue 4, Pages (April 2010) DOI: /j.tics
Glycosidase Inhibition by Macrolide Antibiotics Elucidated by STD-NMR Spectroscopy Ali Sadeghi-Khomami, Michael D. Lumsden, David L. Jakeman Chemistry.
Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)
Venezuela: violence, human rights, and health-care realities
Pharmacogenetics and future drug development and delivery
Lymphatic filariasis elimination efforts in Rufiji, southeastern Tanzania: decline in circulating filarial antigen prevalence in young school children.
Bipolar treatment efficacy
Thank God for Richard Dawkins?
The benefits and harms of breast cancer screening
Punishment beatings and the rule of law
Meta-analysis of randomised controlled trials
Paediatric HIV-1 infection
The Irish health-care system and austerity: sharing the pain
Infections related to totally implantable venous-access ports
Comparative thanatology
Understanding EMPA-REG OUTCOME
Physical activity and prevention of type 2 diabetes
Volume 376, Issue 9743, (September 2010)
Increased body-mass index in patients with narcolepsy
Nicola Low, Joost H Smid  The Lancet Public Health 
Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes:
Gene therapy—where are we?
Ana Victoria Roman, Wilton Perez, Richard Smith  The Lancet 
Breastfeeding in the 21st century
Effect of 3 years of biannual mass drug administration with albendazole on lymphatic filariasis and soil-transmitted helminth infections: a community-based.
Volume 382, Issue 9906, Pages (November 2013)
Brian J Coburn, Sally Blower  The Lancet Infectious Diseases 
Punishment beatings and the rule of law
Understanding EMPA-REG OUTCOME
Effect of supplementation with folic-acid on relation between plasma homocysteine, folate, and vitamin B12  Joe McPartlin, Helene McNulty, Eoin Quinlivan,
Rubella vaccination: must not be business as usual
Paediatric mortality related to pandemic influenza A H1N1 infection in England: an observational population-based study  Nabihah Sachedina, MBBS, Prof.
HIV myths should not be resuscitated
Challenges to eliminate rabies virus infection in China by 2020
Prevalence of tuberculosis, hepatitis C virus, and HIV in homeless people: a systematic review and meta-analysis  Ulla Beijer, PhD, Achim Wolf, MSc, Dr.
Pesticide self-poisoning: thinking outside the box
Volume 385, Issue 9986, Pages (June 2015)
Michael J Goldacre, Jenny J Maisonneuve  The Lancet 
Effect of development assistance on domestic health expenditures
CCR5-Δ32 gene deletion in HIV-1 infected patients
Confessions of a journal junkie
Infant-feeding patterns and HIV-1 transmission
The wonders of the recurated Wellcome Collection
Errata The Lancet Infectious Diseases
Volume 393, Issue 10172, Pages (February 2019)
Telling it like it isn't: truth and lies in a post-9/11 world
Peter J White, P Joanna Lewis  The Lancet Public Health 
Thank God for Richard Dawkins?
Low-technology approaches
Diagnosis of tuberculous meningitis with invasive pulmonary sampling
Prof GJB van Ommen, PhD, E Bakker, PhD, JT den Dunnen, PhD  The Lancet 
Fish consumption and major depression
ACST: which subgroups will benefit most from carotid endarterectomy?
Prescription for change
Volume 373, Issue 9672, Pages (April 2009)
Costs of eliminating HIV in South Africa have been underestimated
GBD 2016 estimates problematic for South Africa
Infections related to totally implantable venous-access ports
Effectiveness of a triple-drug regimen for global elimination of lymphatic filariasis: a modelling study  Michael A Irvine, PhD, Wilma A Stolk, PhD, Morgan.
Dengue pre-vaccination screening and positive predictive values
A remarkable report card on progress in COPD
Ebola control: rapid diagnostic testing
Difficulties of surgery in the developing world: a personal view
Improving management of neonatal infections
Volume 1, Issue 2, Pages (July 2014)
Living in colour—American children, race, and wellbeing
Comparative thanatology
Autism, maths, and sex: the special triangle
Presentation transcript:

Elimination of lymphatic filariasis Edwin Michael, Mwele N Malecela-Lazaro, James W Kazura  The Lancet  Volume 368, Issue 9533, Pages 362-363 (July 2006) DOI: 10.1016/S0140-6736(06)69100-9 Copyright © 2006 Elsevier Ltd Terms and Conditions

Figure Predictions of Epifil model of filariasis transmission3 (upper panel) and effect of sensitivity of diagnostic test for quantifying change in filarial infection prevalence over time (lower panel) Epifil model estimates of number of years of intervention required by annual diethylcarbamazine/albendazole MDA to achieve target infection threshold of just below 0·5% microfilaria prevalence. The Lancet 2006 368, 362-363DOI: (10.1016/S0140-6736(06)69100-9) Copyright © 2006 Elsevier Ltd Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.